Trials / Completed
CompletedNCT02670642
Open, Randomised, Multi-center Study of on Demand Versus Continuous Esomeprazole Treatment in Patient With GERD
On Demand vs Continuous Treatment of Endoscopy Negative Subjects With Gastroesophageal Reflux Disease (GERD) With Esomeprazole 20-mg Once Daily Over a 6 Months Long Term Treatment Phase. An Open, Randomised, Multicenter Study. NEED.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 877 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare on demand with continuous treatment of endoscopy negative subjects with gastroesophageal reflux disease (GERD), with esomeprazole 20-mg once daily, with regards to willingness to continue in the study as a result of satisfactory treatment over a six-month long term management period, after initial symptom relief.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Esomeprazole | Proton pump inhibitor |
Timeline
- Start date
- 2001-08-01
- Primary completion
- 2002-11-01
- Completion
- 2002-11-01
- First posted
- 2016-02-02
- Last updated
- 2016-02-02
Locations
60 sites across 5 countries: Austria, France, Germany, South Africa, Spain
Source: ClinicalTrials.gov record NCT02670642. Inclusion in this directory is not an endorsement.